In this Chapter, we’ll examine:
-
Why Price Controls are Problematic
-
Drugs Going Generic Is a Built in Price Control. (Unless they don’t go generic.)
-
The impact of the Inflation Reduction Act
-
Borrowing from Other Countries
-
Ignoring Patents
- TRIPS Waivers, March-In Rights
-
Guaranteed Contracts
-
The X-Prize Model and PASTEUR
-
Ex-US Patent Enforcement/Lack Thereof
-
Value and GCEA